Editor's Note Cardiothoracic surgeons at Emory University Hospital have conducted the first US implantation of the BrioVAD System, a new ventricular assist device (VAD) from BrioHealth Solutions, Cardiovascular Business News reported November 25. According to the article, the BrioVAD System features a magnetically suspended, hemocompatible pump designed to minimize adverse…

Read More

Editor's Note The Heart Rhythm Society (HRS) announced the formation of Heart Rhythm Advocates, a new 501(c)(4) nonprofit advocacy organization aimed at bolstering support for cardiac electrophysiology (EP), Cardiac Rhythm News October 23 reports. This initiative complements HRS's existing 501(c)(3) nonprofit structure and responds to the increasing prevalence of atrial…

Read More

Editor's Note In a series of interviews with STAT, 11 cardiologists and other clinicians, including the FDA commissioner, said a crisis in primary care is dragging back progress in the nation’s cardiovascular health. Published October 15, the article begins with commentary on a stark warning from the American Heart Association…

Read More

Editor's Note Research shows atrial fibrillation (Afib), a heart rhythm disorder, affects 10.5 million US adults—three times more than previously believed, HealthDay News reported September 12. The article focuses on a study from the University of California, San Francisco (UCSF), published in the Journal of the American College of Cardiology.…

Read More

Editor's Note Although data suggest transcatheter edge-to-edge repair (TEER) using the MitraClip device may offer similar outcomes to mitral valve surgery in patients with heart failure and functional mitral regurgitation (FMR), experts have criticized the research, TCT MD reported September 1. Presented at the recent European Society of Cardiology (ESC)…

Read More

Editor's Note A recent study from two tertiary care centers highlighted significant sex differences in long-term outcomes after cardiac surgery, especially concerning postoperative atrial fibrillation (postopAF), MedPage August 21 reports. The study, published in JAMA Network, found that while women were less likely than men to develop postopAF following a…

Read More

Editor's Note The US Food and Drug Administration (FDA) has designated Defibtech, LLC’s recall of RMU-2000 ARM XR Chest Compression Devices as Class 1, the most severe category indicating serious risk of injury or death. A motor issue could stop  compressions in adults whose hearts suddenly stop, according to the…

Read More

Editor's Note Using a patient’s stem cells to 3D-print patches to place over damaged areas of the heart could provide an alternative to invasive surgery, according to new research detailed in a June 9 report from the Australian Broadcasting Corporation (ABC). Although the technology has yet to be tested on…

Read More

Editor's Note The lack of available hearts for transplantation combined with the recent recall of Abbott’s HeartMate 3 left ventricular assist device (LVAD) “makes the current therapy landscape for heart failure much more dire,” according to a May 20 report in Medical Device Network. The recall of the device, which…

Read More

Editor's Note More than 45 years after surgery, Mary Ann Kozlowski’s mechanical heart valves are still pumping—and Guinness is reviewing an application to list her as the new world record-holder for longevity of a double-valve replacement. That’s according to a May 15 report in the Erie-Times News, which detailed how…

Read More